Zacks Research Forecasts CME Group FY2024 Earnings

CME Group Inc. (NASDAQ:CME) – Analysts at Zacks Research issued their FY2024 earnings estimates for CME Group in a note issued to investors on Wednesday, November 13th. Zacks Research analyst T. De forecasts that the financial services provider will earn $10.21 per share for the year. The consensus estimate for CME Group’s current full-year earnings is $10.22 per share. Zacks Research also issued estimates for CME Group’s Q4 2025 earnings at $2.56 EPS.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The business had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same quarter in the previous year, the business posted $2.25 EPS. The company’s quarterly revenue was up 18.4% compared to the same quarter last year.

A number of other brokerages also recently issued reports on CME. The Goldman Sachs Group lifted their price target on CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a report on Thursday, October 3rd. JPMorgan Chase & Co. boosted their target price on shares of CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a report on Thursday, July 25th. Oppenheimer raised their price target on shares of CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a report on Thursday, October 24th. Piper Sandler raised their target price on shares of CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a research note on Monday, October 28th. Finally, Keefe, Bruyette & Woods lifted their price target on shares of CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a report on Thursday, July 25th. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $224.47.

CME Group Stock Performance

Shares of CME stock opened at $229.66 on Monday. The company’s 50 day moving average is $223.02 and its 200 day moving average is $210.69. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. The firm has a market cap of $82.76 billion, a price-to-earnings ratio of 24.15, a PEG ratio of 5.20 and a beta of 0.55. CME Group has a 52-week low of $190.70 and a 52-week high of $230.74.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be paid a $1.15 dividend. This represents a $4.60 annualized dividend and a dividend yield of 2.00%. The ex-dividend date is Monday, December 9th. CME Group’s dividend payout ratio is currently 48.37%.

Insider Activity at CME Group

In related news, insider Timothy Francis Mccourt sold 1,374 shares of CME Group stock in a transaction dated Monday, October 28th. The stock was sold at an average price of $227.12, for a total value of $312,062.88. Following the completion of the transaction, the insider now owns 7,275 shares in the company, valued at $1,652,298. The trade was a 15.89 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now owns 55,607 shares in the company, valued at $11,932,706.13. This represents a 12.01 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 15,621 shares of company stock worth $3,441,063 in the last three months. Company insiders own 0.30% of the company’s stock.

Institutional Investors Weigh In On CME Group

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Capital International Investors grew its position in shares of CME Group by 24.1% in the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock valued at $3,403,557,000 after purchasing an additional 3,069,806 shares during the period. PineStone Asset Management Inc. boosted its holdings in CME Group by 137.6% in the 2nd quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock worth $444,443,000 after buying an additional 1,309,097 shares during the last quarter. Assenagon Asset Management S.A. increased its stake in CME Group by 577.9% during the 2nd quarter. Assenagon Asset Management S.A. now owns 645,330 shares of the financial services provider’s stock worth $126,872,000 after buying an additional 550,133 shares in the last quarter. Ameriprise Financial Inc. raised its holdings in shares of CME Group by 11.3% during the second quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock valued at $1,038,676,000 after acquiring an additional 537,758 shares during the last quarter. Finally, International Assets Investment Management LLC lifted its position in shares of CME Group by 21,465.5% in the third quarter. International Assets Investment Management LLC now owns 485,871 shares of the financial services provider’s stock valued at $1,072,070,000 after acquiring an additional 483,618 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.